Correspondence  by unknown
associated with an increased risk of death from sepsis. They further
conclude that TEE is frequently needed to make the diagnosis of
infective endocarditis and should be considered in all patients with S.
aureus bacteremia. We agree that bacteremia is a serious condition and
is associated with morbidity and mortality, and we commend the
authors on their efforts to identify patients with infective endocarditis
among this group. However, we believe that their conclusions are not
justified on the basis of their study.
1. It is unclear exactly what hypothesis the authors were trying to
test and how they designed the study to test it. They appear to want to
evaluate the use of TEE in the diagnosis of infective endocarditis and
to demonstrate that it is better than transthoracic echocardiography
(TTE) for this purpose. This approach is problematic because the
authors used TEE as part of the reference standard (along with the
Duke criteria) for the diagnosis of infective endocarditis. They had no
way of addressing specificity, and the sensitivity of TEE is naturally
better than TTE because they considered TEE the reference standard.
Thus, their study is not appropriately designed to determine whether
TEE is better than TTE in this setting.
2. The authors evaluated only 59% of eligible patients with S.
aureus bacteremia. The remaining patients were not evaluated because
of either patient or physician refusal. Thus, their sample may not be
representative of the intended study population. Furthermore, al-
though the authors present the demographic and clinical characteris-
tics of both the study and excluded groups, they did not report any
statistical comparisons. When we made calculations based on the
present data, there appeared to be significant differences between
included and excluded patients. The proportion of patients with an
unknown source of bacteremia in each group is significantly different
(p 5 0.001), as is the proportion of patients with catheter-related sepsis
(p 5 0.001). These baseline differences are significant even after
adjustment for multiple comparisons and strengthens the premise that
their sample may not be representative of all patients with S. aureus
bacteremia. Specifically, the excluded group had a higher percentage
of unknown infection source and a lower percentage of a catheter
source. How these exclusions affect the authors’ conclusion is unclear;
however, the direction of any bias inherent in the selection of cases
should be addressed.
3. The authors analyzed multiple outcomes between subjects with
and without infective endocarditis. They claim that death due to
Staphylococcus sepsis was significantly more likely in patients with
infective endocarditis. The p value by Fisher exact test for this
comparison is 0.034. Not only is this misreported twice as 0.003 in the
report, but no mention of multiple comparisons is made. With four
outcome measures being compared, the risk of a type I error is 0.20 (if
alpha is 0.05). Using the Bonferroni correction, the alpha value for a
significant difference should have been set at 0.0125. Thus, statistical
significance was not achieved. Hence, there may not be a difference
between the groups with and without infective endocarditis as far as
death due to S. aureus bacteremia.
4. No information was provided concerning the specific treatment
regimens administered during the prospective evaluation. Differences
in treatment regimen in either group would either enhance or dilute
any outcome relation.
In conclusion, the unclear hypothesis, sampling procedure, differ-
ences between included and excluded patients, statistically weak
conclusions and lack of standardized treatment protocols make it
difficult to accept the generalizability of their conclusions. We feel
that this study does not establish routine TEE in patients with S.
aureus bacteremia as the basis for future evaluation of clinical
therapies.
JOSEPH A. GUZZO, MD
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Reply
We thank Guzzo and Simpson for their interest in our report and for
the questions that they raise regarding various aspects of it. We would
like to clarify several points that address these misunderstandings.
Our colleagues suggested that we were using transesophageal
echocardiographic (TEE) findings as our reference standard for the
diagnosis of endocarditis. This suggestion is incorrect. We used the
Duke criteria as the reference standard measure by which the diagno-
sis of endocarditis was made (see Table 2). This diagnostic schema is
both sensitive (1–4) and specific (1,5) for the diagnosis of endocarditis
and has been validated at Duke and elsewhere. TEE findings merely
fulfilled a portion of these diagnostic criteria, which also include
clinical and microbiologic criteria. Thus, the diagnosis of endocarditis
in our report rested upon a validated diagnostic schema.
Guzzo and Simpson suggested that the group of patients undergo-
ing TEE might not be representative of the intended study population
because excluded patients who were significantly more likely to have
no identifiable focus of infection and were significantly less likely to
have an intravascular catheter source of infection. Indeed, these facts
would make excluded patients more likely to have endocarditis, thus
supporting our findings. The absence of an identifiable focus of
infection among patients with Staphylococcus aureus bacteremia is a
powerful risk factor for endocarditis (6), and patients with an intra-
vascular device are at low risk for endocarditis when the catheter is
promptly removed (7–9). Thus, the effect of the excluded patients
would be underestimation of our findings. In other words, had fewer
patients with a nonidentifiable focus of infection been excluded, an
even higher rate of endocarditis might have occurred.
Our colleagues took issue with the statistical evidence surrounding
the mortality of patients with and without endocarditis. We acknowl-
edge that the correct p value for patients dying of S. aureus endocar-
ditis is 0.03, as we reported in the abstract section. Furthermore, as
demonstrated by the fact that our colleagues performed the calcula-
tion, we have provided the discerning reader with the means of
calculating Bonferroni corrections should it be considered necessary.
However, we interpret our finding as significant, because it makes
numerical (15.4% mortality rate among endocarditis patients versus
2.6% among patients without endocarditis) and clinical sense (patients
with endocarditis are more likely to die than patients without endo-
carditis), as well as being statistically valid.
Finally, Guzzo and Simpson suggested that differences in treatment
regimen would have an impact on patient outcome. Although we agree
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with this point, the primary focus of our report was the incremental
benefit of TEE in the evaluation of patients with S. aureus bacteremia
rather than the management of patients with endocarditis.
In conclusion, we respect the points raised by Guzzo and Simpson;
however, we feel that the use of a validated diagnostic reference
standard, the probable underestimation of endocarditis among ex-
cluded patients and the clinically logical conclusions in our study
emphasize the need to consider TEE early in the evaluation of patients
with S. aureus bacteremia.
VANCE G. FOWLER, JR., MD
Duke University Medical Center
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Propagation Velocity of Left Ventricular
Filling Flow Measured by Color M-Mode
Doppler Echocardiography
I read with great interest the report by Duval-Moulin et al. (1)
regarding to the application of color M-mode Doppler to assessing left
ventricular diastolic function. The report indicated that left ventricular
diastolic dysfunction during coronary angioplasty could be assessed by
the propagation velocity of left ventricular early filling flow using color
M-mode Doppler technique and that this index showed good correla-
tion with an invasive variable, tau. Their method was very similar to,
but not the same as, our method, which was reported in the Journal in
1996 (2). In their discussion, they introduced our method as follows:
“Takatsuji et al. used a derived technique by measuring the interval
between the maximal rate of increase of action potential upstroke
(Vmax) at the mitral level and 70% Vmax in the apical region.” There
are several inappropriate notations in this sentence. In our report, the
propagation velocity was defined as follows:
By changing the first aliasing limit sequentially at intervals of
2 cm/s with the use of the baseline shift, a flow velocity higher
than the aliasing velocity could be displayed in blue within red
filling flow signals. First, we located the point of maximal
velocity around the mitral orifice in early diastole, which was
obtained at the center of the minimized aliasing area. Next, we
changed the first aliasing limit to 70% of the maximal velocity
and located the point nearest to the apex on the aliasing
boundary (which is usually obtained in the mid-left ventricle).
The distance/time ratio, that is, the upward slope of the line
connecting these two points, was measured and defined as the
rate of propagation of peak early filling flow velocity.
First, the authors used the terms “action potential” and “Vmax,”
which were not used in our report, and this terminology might mislead
the readers and prevent appropriate understanding of our method.
Second, we did not measure the “interval” but the “distance/time
ratio”; and third, the second measurement point is not “in the apical
region” but “in the mid-left ventricle.” We have some evidence that the
propagation velocity measured by our method is more accurate than
that measured at the wavefront of filling flow, which was used in their
report. Therefore, if they carefully traced our protocol, I believe that
they would obtain better correlation between propagation velocity and
tau. Nevertheless, we appreciate the authors’ results because their
study enhances the usefulness of color M-mode Doppler for evaluating
diastolic function in many clinical settings.
AKIRA KITABATAKE, MD, FACC
Department of Cardiovascular Medicine
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Reply
We have taken into account the different points emphasized by
Kitabatake about the report by Takatsuji et al. (1). As Kitabatake
described, color M-mode Doppler allows remarkably effective obser-
vation of diastolic flow as a function of time and of space.
The color M-mode Doppler method has been developed by several
groups, including Takatsuji et al. (1), Stugaard et al. (2) and ourselves
(3,4). The technique shows correlation of the propagation of early
diastolic flows in the left ventricle with hemodynamic data of relax-
ation, especially the index tau.
With regard to the report of Takatsuji et al. (1) we were naturally
interested in their methods and results, which analyze the rate of
propagation of peak early filling flow. However, their study was
published in the Journal during the review process of our study.
Consequently, we added this new information in the revised version of
our manuscript, which may explain why we did not discuss all the
aspects of the interesting report of Takatsuji et al.
Nevertheless, we would like to point out that in contrast to
Takatsuji et al. (1) and Stugaard et al. (2), we preferred to analyze the
flow front wave at the beginning of filling rather than the later events
of the propagation of peak early filling flow to better evaluate the
relaxation process.
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